|
An initial event notification was received by sequel med tech, llc on 25-jul-2026 and forwarded to millyard advanced medical products, llc on the same day.The user reported that they received pump error alarms from their twiist automated insulin delivery (aid) system.The user's glucose at the time of the alarms was 270 mg/dl.The user gave themselves an injection of lyumjev (insulin lispro) to resolve their glucose and reverted to their backup insulin therapy while awaiting a replacement twiist pump.
|
|
Investigation into the reported event remains ongoing and a supplemental report will be filed once results are available.Additionally, the user's blood glucose level at the time of the pump error alarm was reported as 270 mg/dl.Based on the information available for assessment, a causal relationship between the device and the reported hyperglycemic event cannot be determined; however, this medical device report conservatively considers the hyperglycemia to be an adverse event.The current version of the twiist automated insulin delivery (aid) system user guide provides information regarding system alarms and the recommended actions associated with them, as well as potential causes of hyperglycemia and ways to prevent it.Users are also instructed to have a backup insulin therapy available at all times.No additional information relevant to the reported event has been made available to millyard advanced medical products, llc, for further investigation.
|